RAB1A and hepatocellular carcinoma: In the previous studies, we demonstrated that Rab1A is overexpressed and associated with tumor prognosis in patients with CRC and hepatocellular carcinoma (HCC), promoting tumor growth and metastasis through activating mTORC1 signaling [10, 11].